LeafNLP Demos
Back to explore

Report #2887437

Received Mar 3, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Tinnitus

Symptom narrative

Tinnitus following Shingrix; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tinnitus in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tinnitus (Verbatim: Tinnitus following Shingrix). The outcome of the tinnitus was not reported. It was unknown if the reporter considered the tinnitus to be related to Shingrix. It was unknown if the company considered the tinnitus to be related to Shingrix. Additional Information: GSK Receipt Date: 24-FEB-2026 This case was reported by a patient via interactive digital media. The batch number was not provided and unable to contact the reporter.